Gujarat Themis Biosyn Ltd (GUJTHEM) — Board Meeting | 27 August 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Board to approve preferential fundraise via equity or convertible warrants
💡 Investor Takeaway
The proposed fundraise could dilute existing shareholders if completed.

Gujarat Themis Biosyn Limited announced a board meeting on September 1, 2026, to approve raising funds via preferential issue of equity shares or convertible warrants, pending shareholder and exchange approvals, with insider trading restrictions in place until 48 hours post-announcement.

📄 View Original Announcement (PDF)

About Gujarat Themis Biosyn Ltd (GUJTHEM)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,604.87 Cr

View full GUJTHEM stock details →

📡 Get AI alerts when GUJTHEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GUJTHEM — Free

📊 More GUJTHEM filings

See all GUJTHEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GUJTHEM files new disclosures

Track GUJTHEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GUJTHEM — Free

Free account · 2 AI queries/day